用天然产品向氧化压力:食道癌症治疗的新策略
Fang Cao1, Han-Ling Zhang2, Cui Guo3
1Department of Rehabilitation III, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, Sichuan Province, China.
World journal of gastrointestinal oncology
|March 1, 2024
概括
自然化合物可以通过减少氧化应激来对抗食道癌 (ESC),而氧化应激是其发展和进展的关键因素. 用天然产品准氧化压力为食道癌治疗提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 食道癌 (ESC) 起源于食道粘膜上皮,氧化应激在其发病过程中发挥着重要作用.
- 在ESC中异常的蛋白质和转录因子表达会加剧氧化应激,促进瘤生长,扩散和转移.
- 过度的氧化压力是推动许多癌症的发展和进展的关键标志,包括ESC.
研究的目的:
- 审查天然产品 (NP) 在治疗食道癌症 (ESC) 的潜力.
- 总结ESC治疗中针对氧化应激的治疗前景.
- 为开发基于天然化合物的新型抗ESC药物提供参考.
主要方法:
- 文献综述侧重于氧化应激在ESC中的作用.
- 对抑制反应性氧物种 (ROS) 生产的自然化合物 (类化合物,烯,多,山丁化合物) 的分析.
- 检查由自然化合物调节的分子标和通路,包括介质蛋白,超氧化物脱酶,NF-κB/MAPK和Nrf2/ARE通路.
主要成果:
- 自然化合物有效抑制ROS的产生,并减少ESC中的氧化应激.
- 这些化合物调节关键途径 (例如,细胞因子信号传递,抗氧化酶,转录因子途径) 参与ESC进展.
- 用天然产品向瘤氧化应激表明了抑制ESC发生和进展的潜力.
结论:
- 通过向氧化应激,天然产品显示出作为食道癌治疗策略的显著前景.
- 氧化应激代表了抗ESC治疗的可行新目标,天然化合物提供了丰富的潜在治疗来源.
- 进一步严格的临床研究对于验证各种天然产品在治疗食道癌症中的有效性至关重要.
相关概念视频
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Barrett Esophagus-II: Clinical Manifestations and Management
150
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
150


